Healthcare costs are rising.
eMed is designed to bend the curve.
A GLP-1 program built to maximize adherence, improve workforce health outcomes, and lower the cost of coverage.

Situation
Obesity is already on your books.
Whether you cover GLP-1s or not, obesity already costs employers millions in claims, absenteeism and lost productivity.
The bill is just hiding in different line items.
PROVEN OUTCOMES
Industry leading adherence. Real results. Measured from day one.
high cholesterol
Source: Aon Workforce-Focused Analysis on GLP-1s, Phase Two Findings; January 13, 2026
*Among matched lab cohort participants with available data, observed reduction in the proportion with HbA1c above 5.7% over the measurement period.Individual results vary. Outcomes are not guaranteed.
You’ve got GLP-1 coverage challenges. eMed has solutions.
eMed’s unique at home screening kit makes it easy to help the most at-risk members
Screens for/monitors diabetes; reflects average blood glucose over 2–3 months.
Simple, reproducible indicator of kidney filtration.
Biomarker for systemic inflammation in cardiovascular risk assessment.
Sensitive marker of hepatobiliary dysfunction and oxidative stress.
Screens for dyslipidemia; assesses cardiovascular risk via cholesterol levels (TC, LDL, HDL).
Screens for megaloblastic anemia and GLP-1 related nutritional deficiencies.

The eMed Member Journey






What others are saying about eMed
Our Partners
.avif)

.avif)

Real people. Real results.
Connect with us
Every workforce is different.
eMed offers flexible plans built to fit your population, your priorities and your bottom line.



